Arpa Garay - May 3, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
SVP Human Health Global Mktg.
Signature
/s/ Kelly E. W. Grez, as attorney-in-fact for Arpa Garay
Stock symbol
MRK
Transactions as of
May 3, 2022
Transactions value $
$56,441
Form type
4
Date filed
5/5/2022, 05:24 PM
Previous filing
May 3, 2022
Next filing
Jun 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $79K +907 +62.08% $87.10 2.37K May 4, 2022 Direct
transaction MRK Common Stock Tax liability -$22.6K -259 -10.94% $87.10 2.11K May 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -907 -33.27% $0.00 1.82K May 4, 2022 Common Stock 907 Direct F2, F3
transaction MRK Stock Option (Right to Buy) Award $0 +21.4K $0.00 21.4K May 3, 2022 Common Stock 21.4K $87.10 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
F4 The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.